1 Study Coverage
    1.1 Drug Closed System Transmission Product Introduction
    1.2 Market by Type
        1.2.1 Global Drug Closed System Transmission Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Closed Vial Access Device
        1.2.3 Closed Syringe Safety Device
        1.2.4 Closed Bag/Line Access Device
    1.3 Market by Application
        1.3.1 Global Drug Closed System Transmission Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Drug Closed System Transmission Sales Estimates and Forecasts 2017-2028
    2.2 Global Drug Closed System Transmission Revenue Estimates and Forecasts 2017-2028
    2.3 Global Drug Closed System Transmission Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Drug Closed System Transmission Sales by Region
        2.4.1 Global Drug Closed System Transmission Sales by Region (2017-2022)
        2.4.2 Global Sales Drug Closed System Transmission by Region (2023-2028)
    2.5 Global Drug Closed System Transmission Revenue by Region
        2.5.1 Global Drug Closed System Transmission Revenue by Region (2017-2022)
        2.5.2 Global Drug Closed System Transmission Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Drug Closed System Transmission Sales by Manufacturers
        3.1.1 Global Top Drug Closed System Transmission Manufacturers by Sales (2017-2022)
        3.1.2 Global Drug Closed System Transmission Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug Closed System Transmission in 2021
    3.2 Global Drug Closed System Transmission Revenue by Manufacturers
        3.2.1 Global Drug Closed System Transmission Revenue by Manufacturers (2017-2022)
        3.2.2 Global Drug Closed System Transmission Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Drug Closed System Transmission Revenue in 2021
    3.3 Global Drug Closed System Transmission Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Drug Closed System Transmission Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Drug Closed System Transmission Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Drug Closed System Transmission Sales by Type
        4.1.1 Global Drug Closed System Transmission Historical Sales by Type (2017-2022)
        4.1.2 Global Drug Closed System Transmission Forecasted Sales by Type (2023-2028)
        4.1.3 Global Drug Closed System Transmission Sales Market Share by Type (2017-2028)
    4.2 Global Drug Closed System Transmission Revenue by Type
        4.2.1 Global Drug Closed System Transmission Historical Revenue by Type (2017-2022)
        4.2.2 Global Drug Closed System Transmission Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Drug Closed System Transmission Revenue Market Share by Type (2017-2028)
    4.3 Global Drug Closed System Transmission Price by Type
        4.3.1 Global Drug Closed System Transmission Price by Type (2017-2022)
        4.3.2 Global Drug Closed System Transmission Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Drug Closed System Transmission Sales by Application
        5.1.1 Global Drug Closed System Transmission Historical Sales by Application (2017-2022)
        5.1.2 Global Drug Closed System Transmission Forecasted Sales by Application (2023-2028)
        5.1.3 Global Drug Closed System Transmission Sales Market Share by Application (2017-2028)
    5.2 Global Drug Closed System Transmission Revenue by Application
        5.2.1 Global Drug Closed System Transmission Historical Revenue by Application (2017-2022)
        5.2.2 Global Drug Closed System Transmission Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Drug Closed System Transmission Revenue Market Share by Application (2017-2028)
    5.3 Global Drug Closed System Transmission Price by Application
        5.3.1 Global Drug Closed System Transmission Price by Application (2017-2022)
        5.3.2 Global Drug Closed System Transmission Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Drug Closed System Transmission Market Size by Type
        6.1.1 North America Drug Closed System Transmission Sales by Type (2017-2028)
        6.1.2 North America Drug Closed System Transmission Revenue by Type (2017-2028)
    6.2 North America Drug Closed System Transmission Market Size by Application
        6.2.1 North America Drug Closed System Transmission Sales by Application (2017-2028)
        6.2.2 North America Drug Closed System Transmission Revenue by Application (2017-2028)
    6.3 North America Drug Closed System Transmission Market Size by Country
        6.3.1 North America Drug Closed System Transmission Sales by Country (2017-2028)
        6.3.2 North America Drug Closed System Transmission Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Drug Closed System Transmission Market Size by Type
        7.1.1 Europe Drug Closed System Transmission Sales by Type (2017-2028)
        7.1.2 Europe Drug Closed System Transmission Revenue by Type (2017-2028)
    7.2 Europe Drug Closed System Transmission Market Size by Application
        7.2.1 Europe Drug Closed System Transmission Sales by Application (2017-2028)
        7.2.2 Europe Drug Closed System Transmission Revenue by Application (2017-2028)
    7.3 Europe Drug Closed System Transmission Market Size by Country
        7.3.1 Europe Drug Closed System Transmission Sales by Country (2017-2028)
        7.3.2 Europe Drug Closed System Transmission Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Drug Closed System Transmission Market Size by Type
        8.1.1 Asia Pacific Drug Closed System Transmission Sales by Type (2017-2028)
        8.1.2 Asia Pacific Drug Closed System Transmission Revenue by Type (2017-2028)
    8.2 Asia Pacific Drug Closed System Transmission Market Size by Application
        8.2.1 Asia Pacific Drug Closed System Transmission Sales by Application (2017-2028)
        8.2.2 Asia Pacific Drug Closed System Transmission Revenue by Application (2017-2028)
    8.3 Asia Pacific Drug Closed System Transmission Market Size by Region
        8.3.1 Asia Pacific Drug Closed System Transmission Sales by Region (2017-2028)
        8.3.2 Asia Pacific Drug Closed System Transmission Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Drug Closed System Transmission Market Size by Type
        9.1.1 Latin America Drug Closed System Transmission Sales by Type (2017-2028)
        9.1.2 Latin America Drug Closed System Transmission Revenue by Type (2017-2028)
    9.2 Latin America Drug Closed System Transmission Market Size by Application
        9.2.1 Latin America Drug Closed System Transmission Sales by Application (2017-2028)
        9.2.2 Latin America Drug Closed System Transmission Revenue by Application (2017-2028)
    9.3 Latin America Drug Closed System Transmission Market Size by Country
        9.3.1 Latin America Drug Closed System Transmission Sales by Country (2017-2028)
        9.3.2 Latin America Drug Closed System Transmission Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Drug Closed System Transmission Market Size by Type
        10.1.1 Middle East and Africa Drug Closed System Transmission Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Drug Closed System Transmission Revenue by Type (2017-2028)
    10.2 Middle East and Africa Drug Closed System Transmission Market Size by Application
        10.2.1 Middle East and Africa Drug Closed System Transmission Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Drug Closed System Transmission Revenue by Application (2017-2028)
    10.3 Middle East and Africa Drug Closed System Transmission Market Size by Country
        10.3.1 Middle East and Africa Drug Closed System Transmission Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Drug Closed System Transmission Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Equashield
        11.1.1 Equashield Corporation Information
        11.1.2 Equashield Overview
        11.1.3 Equashield Drug Closed System Transmission Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Equashield Drug Closed System Transmission Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Equashield Recent Developments
    11.2 BD Medical
        11.2.1 BD Medical Corporation Information
        11.2.2 BD Medical Overview
        11.2.3 BD Medical Drug Closed System Transmission Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 BD Medical Drug Closed System Transmission Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 BD Medical Recent Developments
    11.3 Teva Medical
        11.3.1 Teva Medical Corporation Information
        11.3.2 Teva Medical Overview
        11.3.3 Teva Medical Drug Closed System Transmission Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Teva Medical Drug Closed System Transmission Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Teva Medical Recent Developments
    11.4 ICU Medical
        11.4.1 ICU Medical Corporation Information
        11.4.2 ICU Medical Overview
        11.4.3 ICU Medical Drug Closed System Transmission Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 ICU Medical Drug Closed System Transmission Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 ICU Medical Recent Developments
    11.5 Corvida Medical
        11.5.1 Corvida Medical Corporation Information
        11.5.2 Corvida Medical Overview
        11.5.3 Corvida Medical Drug Closed System Transmission Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Corvida Medical Drug Closed System Transmission Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Corvida Medical Recent Developments
    11.6 B. Braun
        11.6.1 B. Braun Corporation Information
        11.6.2 B. Braun Overview
        11.6.3 B. Braun Drug Closed System Transmission Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 B. Braun Drug Closed System Transmission Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 B. Braun Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Drug Closed System Transmission Industry Chain Analysis
    12.2 Drug Closed System Transmission Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Drug Closed System Transmission Production Mode & Process
    12.4 Drug Closed System Transmission Sales and Marketing
        12.4.1 Drug Closed System Transmission Sales Channels
        12.4.2 Drug Closed System Transmission Distributors
    12.5 Drug Closed System Transmission Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Drug Closed System Transmission Industry Trends
    13.2 Drug Closed System Transmission Market Drivers
    13.3 Drug Closed System Transmission Market Challenges
    13.4 Drug Closed System Transmission Market Restraints
14 Key Findings in The Global Drug Closed System Transmission Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Drug Closed System Transmission Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Closed Vial Access Device
    Table 3. Major Manufacturers of Closed Syringe Safety Device
    Table 4. Major Manufacturers of Closed Bag/Line Access Device
    Table 5. Global Drug Closed System Transmission Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Drug Closed System Transmission Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Drug Closed System Transmission Sales by Region (2017-2022) & (K Units)
    Table 8. Global Drug Closed System Transmission Sales Market Share by Region (2017-2022)
    Table 9. Global Drug Closed System Transmission Sales by Region (2023-2028) & (K Units)
    Table 10. Global Drug Closed System Transmission Sales Market Share by Region (2023-2028)
    Table 11. Global Drug Closed System Transmission Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Drug Closed System Transmission Revenue Market Share by Region (2017-2022)
    Table 13. Global Drug Closed System Transmission Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Drug Closed System Transmission Revenue Market Share by Region (2023-2028)
    Table 15. Global Drug Closed System Transmission Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Drug Closed System Transmission Sales Share by Manufacturers (2017-2022)
    Table 17. Global Drug Closed System Transmission Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Drug Closed System Transmission Revenue Share by Manufacturers (2017-2022)
    Table 19. Drug Closed System Transmission Price by Manufacturers (2017-2022) &(US$/Unit)
    Table 20. Global Drug Closed System Transmission Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Drug Closed System Transmission by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Closed System Transmission as of 2021)
    Table 22. Drug Closed System Transmission Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Drug Closed System Transmission Product Offered
    Table 24. Date of Manufacturers Enter into Drug Closed System Transmission Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Drug Closed System Transmission Sales by Type (2017-2022) & (K Units)
    Table 27. Global Drug Closed System Transmission Sales by Type (2023-2028) & (K Units)
    Table 28. Global Drug Closed System Transmission Sales Share by Type (2017-2022)
    Table 29. Global Drug Closed System Transmission Sales Share by Type (2023-2028)
    Table 30. Global Drug Closed System Transmission Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Drug Closed System Transmission Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Drug Closed System Transmission Revenue Share by Type (2017-2022)
    Table 33. Global Drug Closed System Transmission Revenue Share by Type (2023-2028)
    Table 34. Drug Closed System Transmission Price by Type (2017-2022) & (US$/Unit)
    Table 35. Global Drug Closed System Transmission Price Forecast by Type (2023-2028) & (US$/Unit)
    Table 36. Global Drug Closed System Transmission Sales by Application (2017-2022) & (K Units)
    Table 37. Global Drug Closed System Transmission Sales by Application (2023-2028) & (K Units)
    Table 38. Global Drug Closed System Transmission Sales Share by Application (2017-2022)
    Table 39. Global Drug Closed System Transmission Sales Share by Application (2023-2028)
    Table 40. Global Drug Closed System Transmission Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Drug Closed System Transmission Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Drug Closed System Transmission Revenue Share by Application (2017-2022)
    Table 43. Global Drug Closed System Transmission Revenue Share by Application (2023-2028)
    Table 44. Drug Closed System Transmission Price by Application (2017-2022) & (US$/Unit)
    Table 45. Global Drug Closed System Transmission Price Forecast by Application (2023-2028) & (US$/Unit)
    Table 46. North America Drug Closed System Transmission Sales by Type (2017-2022) & (K Units)
    Table 47. North America Drug Closed System Transmission Sales by Type (2023-2028) & (K Units)
    Table 48. North America Drug Closed System Transmission Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Drug Closed System Transmission Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Drug Closed System Transmission Sales by Application (2017-2022) & (K Units)
    Table 51. North America Drug Closed System Transmission Sales by Application (2023-2028) & (K Units)
    Table 52. North America Drug Closed System Transmission Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Drug Closed System Transmission Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Drug Closed System Transmission Sales by Country (2017-2022) & (K Units)
    Table 55. North America Drug Closed System Transmission Sales by Country (2023-2028) & (K Units)
    Table 56. North America Drug Closed System Transmission Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Drug Closed System Transmission Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Drug Closed System Transmission Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Drug Closed System Transmission Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Drug Closed System Transmission Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Drug Closed System Transmission Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Drug Closed System Transmission Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Drug Closed System Transmission Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Drug Closed System Transmission Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Drug Closed System Transmission Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Drug Closed System Transmission Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Drug Closed System Transmission Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Drug Closed System Transmission Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Drug Closed System Transmission Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Drug Closed System Transmission Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Drug Closed System Transmission Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Drug Closed System Transmission Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Drug Closed System Transmission Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Drug Closed System Transmission Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Drug Closed System Transmission Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Drug Closed System Transmission Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Drug Closed System Transmission Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Drug Closed System Transmission Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Drug Closed System Transmission Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Drug Closed System Transmission Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Drug Closed System Transmission Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Drug Closed System Transmission Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Drug Closed System Transmission Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Drug Closed System Transmission Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Drug Closed System Transmission Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Drug Closed System Transmission Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Drug Closed System Transmission Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Drug Closed System Transmission Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Drug Closed System Transmission Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Drug Closed System Transmission Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Drug Closed System Transmission Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Drug Closed System Transmission Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Drug Closed System Transmission Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Drug Closed System Transmission Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Drug Closed System Transmission Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Drug Closed System Transmission Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Drug Closed System Transmission Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Drug Closed System Transmission Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Drug Closed System Transmission Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Drug Closed System Transmission Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Drug Closed System Transmission Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Drug Closed System Transmission Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Drug Closed System Transmission Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Drug Closed System Transmission Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Drug Closed System Transmission Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Equashield Corporation Information
    Table 107. Equashield Description and Major Businesses
    Table 108. Equashield Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 109. Equashield Drug Closed System Transmission Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Equashield Recent Developments
    Table 111. BD Medical Corporation Information
    Table 112. BD Medical Description and Major Businesses
    Table 113. BD Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 114. BD Medical Drug Closed System Transmission Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. BD Medical Recent Developments
    Table 116. Teva Medical Corporation Information
    Table 117. Teva Medical Description and Major Businesses
    Table 118. Teva Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 119. Teva Medical Drug Closed System Transmission Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Teva Medical Recent Developments
    Table 121. ICU Medical Corporation Information
    Table 122. ICU Medical Description and Major Businesses
    Table 123. ICU Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 124. ICU Medical Drug Closed System Transmission Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. ICU Medical Recent Developments
    Table 126. Corvida Medical Corporation Information
    Table 127. Corvida Medical Description and Major Businesses
    Table 128. Corvida Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 129. Corvida Medical Drug Closed System Transmission Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Corvida Medical Recent Developments
    Table 131. B. Braun Corporation Information
    Table 132. B. Braun Description and Major Businesses
    Table 133. B. Braun Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 134. B. Braun Drug Closed System Transmission Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. B. Braun Recent Developments
    Table 136. Key Raw Materials Lists
    Table 137. Raw Materials Key Suppliers Lists
    Table 138. Drug Closed System Transmission Distributors List
    Table 139. Drug Closed System Transmission Customers List
    Table 140. Drug Closed System Transmission Market Trends
    Table 141. Drug Closed System Transmission Market Drivers
    Table 142. Drug Closed System Transmission Market Challenges
    Table 143. Drug Closed System Transmission Market Restraints
    Table 144. Research Programs/Design for This Report
    Table 145. Key Data Information from Secondary Sources
    Table 146. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug Closed System Transmission Product Picture
    Figure 3. Global Drug Closed System Transmission Market Share by Type in 2021 & 2028
    Figure 3. Closed Vial Access Device Product Picture
    Figure 4. Closed Syringe Safety Device Product Picture
    Figure 5. Closed Bag/Line Access Device Product Picture
    Figure 6. Global Drug Closed System Transmission Market Share by Application in 2021 & 2028
    Figure 7. Hospital
    Figure 8. Clinic
    Figure 9. Other
    Figure 10. Drug Closed System Transmission Report Years Considered
    Figure 11. Global Drug Closed System Transmission Sales 2017-2028 (K Units)
    Figure 12. Global Drug Closed System Transmission Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Drug Closed System Transmission Revenue 2017-2028 (US$ Million)
    Figure 14. Global Drug Closed System Transmission Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Drug Closed System Transmission Sales Market Share by Region (2017-2022)
    Figure 16. Global Drug Closed System Transmission Sales Market Share by Region (2023-2028)
    Figure 17. North America Drug Closed System Transmission Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Drug Closed System Transmission Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Drug Closed System Transmission Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Drug Closed System Transmission Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Drug Closed System Transmission Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Drug Closed System Transmission Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Drug Closed System Transmission Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Drug Closed System Transmission Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Drug Closed System Transmission Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Drug Closed System Transmission Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Drug Closed System Transmission Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Drug Closed System Transmission in the World: Market Share by Drug Closed System Transmission Revenue in 2021
    Figure 29. Global Drug Closed System Transmission Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Drug Closed System Transmission Sales Market Share by Type (2017-2028)
    Figure 31. Global Drug Closed System Transmission Revenue Market Share by Type (2017-2028)
    Figure 32. Global Drug Closed System Transmission Sales Market Share by Application (2017-2028)
    Figure 33. Global Drug Closed System Transmission Revenue Market Share by Application (2017-2028)
    Figure 34. North America Drug Closed System Transmission Sales Market Share by Type (2017-2028)
    Figure 35. North America Drug Closed System Transmission Revenue Market Share by Type (2017-2028)
    Figure 36. North America Drug Closed System Transmission Sales Market Share by Application (2017-2028)
    Figure 37. North America Drug Closed System Transmission Revenue Market Share by Application (2017-2028)
    Figure 38. North America Drug Closed System Transmission Sales Share by Country (2017-2028)
    Figure 39. North America Drug Closed System Transmission Revenue Share by Country (2017-2028)
    Figure 40. U.S. Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Drug Closed System Transmission Sales Market Share by Type (2017-2028)
    Figure 43. Europe Drug Closed System Transmission Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Drug Closed System Transmission Sales Market Share by Application (2017-2028)
    Figure 45. Europe Drug Closed System Transmission Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Drug Closed System Transmission Sales Share by Country (2017-2028)
    Figure 47. Europe Drug Closed System Transmission Revenue Share by Country (2017-2028)
    Figure 48. Germany Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 49. France Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Drug Closed System Transmission Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Drug Closed System Transmission Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Drug Closed System Transmission Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Drug Closed System Transmission Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Drug Closed System Transmission Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Drug Closed System Transmission Revenue Share by Region (2017-2028)
    Figure 59. China Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 62. India Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Drug Closed System Transmission Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Drug Closed System Transmission Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Drug Closed System Transmission Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Drug Closed System Transmission Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Drug Closed System Transmission Sales Share by Country (2017-2028)
    Figure 74. Latin America Drug Closed System Transmission Revenue Share by Country (2017-2028)
    Figure 75. Mexico Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Drug Closed System Transmission Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Drug Closed System Transmission Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Drug Closed System Transmission Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Drug Closed System Transmission Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Drug Closed System Transmission Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Drug Closed System Transmission Revenue Share by Country (2017-2028)
    Figure 84. Turkey Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 86. UAE Drug Closed System Transmission Revenue (2017-2028) & (US$ Million)
    Figure 87. Drug Closed System Transmission Value Chain
    Figure 88. Drug Closed System Transmission Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed